Safety and Efficacy of COVIDEX™ Therapy in Management of Adult COVID-19 Patients in Uganda.
Status:
Not yet recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The SARS-CoV-2 pandemic continues to grow, with over 350,000 new infections and over 7,000
daily global deaths in May 2021 (WHO, 2021a). The current supplies of protective vaccines are
too low to cover the worldwide demand hence researchers worldwide are urgently looking for
interventions to prevent new infections, prevent disease progression, and lessen disease
severity for those already infected.
While a number of claims on efficacy of herbal remedies on COVID-19 have been made, to our
knowledge none of such claims have gained on scientific basis for continued use or further
research and development of the constituents into investigational products.
In Uganda, one of such herbal remedies is COVIDEX, this study therefore seeks to investigate
the safety and efficacy of COVIDEX in the management of COVID-19.